Please login to the form below
Influence mapping to improve the efficiency and effectiveness of your messaging
As companies work to find innovative marketing techniques to cut through the noise, influence mapping has seen an increase in popularity. Associate Consultant Pany Koizi talks through how to get the most out of the influence mapping process.
The perpetually evolving nature of the healthcare market means that healthcare companies regularly find themselves in new and unfamiliar environments. As companies work to find innovative marketing techniques to cut through the noise, influence mapping has seen an increase in popularity. Such mapping programs are designed with the objective of moving away from the traditionally ad-hoc nature of stakeholder engagement, and into the more forward-looking strategic engagement planning process.
Associate Consultant Pany Koizi talks through how to get the most out of the influence mapping process.
Stakeholder influence maps are constructed for any number of given decisions, but a common feature in each of these situations is reacting to a change in market dynamics. An example could be a pharmaceutical company exploiting a new indication for an existing drug. Given the new indication, the company is unlikely to be aware of the influencers within the new therapy area. Visualising the environment through a stakeholder influence map would allow the company to better identify and create more-informed engage plans for influential stakeholders.
1. Optimising relevance
Communication is only as effective as the relevance of the message. A typical stakeholder map will also house information that allows team members to create a custom plan based on the drivers and pain points of individual stakeholders. A comprehensive stakeholder map will also outline preferred sources of information and mediums of communication for each stakeholder, further increasing the relevance and effectiveness of the message. It is also possible to analyse the prevalence of drivers or pain points within networks or micro-networks, allowing the optimisation of message for entire communities of stakeholders.
![]()
Associate Consultant Pany Koizi talks through how to get the most out of the influence mapping process.
Stakeholder and influencer mapping: a roadmap to success
Beyond the visible organisational structure lies a more complex and intricate series of connections that flow across individuals, resources, and organisations. A stakeholder influence map visualises the myriad connections between stakeholders that dictate how a decision is made. In fluctuating market conditions, healthcare companies can use stakeholder influence maps as, quite simply, a roadmap to identify and reach the most influential stakeholders for the decision they want to target.Stakeholder influence maps are constructed for any number of given decisions, but a common feature in each of these situations is reacting to a change in market dynamics. An example could be a pharmaceutical company exploiting a new indication for an existing drug. Given the new indication, the company is unlikely to be aware of the influencers within the new therapy area. Visualising the environment through a stakeholder influence map would allow the company to better identify and create more-informed engage plans for influential stakeholders.
Leveraging stakeholder influence maps to communicate a relevant, credible and coordinated message
In addition to analysing networks and identifying influential stakeholders, influence maps are designed to drive the strategic engagement planning process in three ways:1. Optimising relevance
Communication is only as effective as the relevance of the message. A typical stakeholder map will also house information that allows team members to create a custom plan based on the drivers and pain points of individual stakeholders. A comprehensive stakeholder map will also outline preferred sources of information and mediums of communication for each stakeholder, further increasing the relevance and effectiveness of the message. It is also possible to analyse the prevalence of drivers or pain points within networks or micro-networks, allowing the optimisation of message for entire communities of stakeholders.
Download the full article from Blue Latitude Health
Company Details
Blue Latitude Health
+44 203 328 1840
Address:
Blue Latitude Health (UK)
140 Aldersgate Street
London
EC1A 4HY
United Kingdom
Latest content on this profile
- Three strategies for managing loss of exclusivity successfully
- Consultant, Claire Taylor explains why you should be strategically planning your LOE strategy years in advance.
Blue Latitude Health
- What does the future hold for Medical Affairs?
- Lori Lush, Head of Fishawack Medical, reveals why she’s driven to tell impactful scientific stories, the benefits of cross-functional collaboration, and the trends she predicts for the next five years.
Blue Latitude Health
- Mistrust in medical research: a patient perspective
- The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the life sciences industry can do to rebuild trust.
Blue Latitude Health
- Real-world evidence: breaking boundaries in rare disease
- Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and Senior Consultant Craig Moore explore the benefits of using real-world evidence and the common pitfalls life science companies should avoid.
Blue Latitude Health
- The heavy toll of COVID-19 on cancer patients
- We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of this lost time for patients?
Blue Latitude Health
- Unpacking rare diseases in the first edition of Delta magazine
- Fishawack Health launches Delta magazine with a deep dive into rare disease commercialization
Blue Latitude Health
